Plexin D1 as a Potential Biomarker inPM/DM

计划入组 66 人 · 首次发布于 2022 年 12 月 6 日

Plexin B2 Gene Expression and Polymorphisms in Psoriasis

计划入组 200 人 · 首次发布于 2022 年 1 月 11 日

Doxazosin an a1 Antagonist for Alcohol Dependence

计划入组 41 人 · 首次发布于 2011 年 9 月 20 日

Coumermycin A1

C₅₅H₅₉N₅O₂₀

Esperamicin-A1

LL-A1

PLEXAA LTD

United Kingdom

Plexium, Inc.

United States

ALEXION PHARMACEUTICALS, INC.

United States

Find Therapeutics Doses First Subject in Phase I Trial of FTX-101 for Chronic Optic Neuropathy

Aurobindo Pharma's Apitoria to Acquire 80% Stake in A1 Biochem CRO for $17 Million, Building Integrated CRDMO Platform

ResoTher's Annexin A1 Mimetic RTP-026 Shows 8-Point LVEF Gain in Phase 2a STEMI Trial, Clearing Acquisition Hurdle